Total Payments
$5,627
2024 Payments
$425.06
Companies
35
Transactions
369
Medicare Patients
7,166
Medicare Billing
$354,449
Payment Breakdown by Category
Food & Beverage$5,606 (99.6%)
Education$20.67 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,606 | 365 | 99.6% |
| Education | $20.67 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $932.97 | 62 | $0 (2024) |
| ABBVIE INC. | $793.99 | 58 | $0 (2024) |
| PFIZER INC. | $773.81 | 74 | $0 (2024) |
| GlaxoSmithKline, LLC. | $465.79 | 28 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $340.97 | 11 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $328.49 | 23 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $310.09 | 17 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $286.23 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $161.49 | 5 | $0 (2022) |
| Amgen Inc. | $151.43 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $425.06 | 26 | Almatica Pharma LLC ($81.84) |
| 2023 | $893.90 | 55 | AbbVie Inc. ($275.10) |
| 2022 | $847.84 | 58 | ABBVIE INC. ($293.21) |
| 2021 | $900.14 | 67 | PFIZER INC. ($176.22) |
| 2020 | $149.06 | 9 | PFIZER INC. ($56.29) |
| 2019 | $188.20 | 12 | Novo Nordisk Inc ($148.92) |
| 2018 | $766.14 | 47 | Novo Nordisk Inc ($175.98) |
| 2017 | $1,457 | 95 | Janssen Pharmaceuticals, Inc ($298.86) |
All Payment Transactions
369 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/27/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: ANTI-ANXIETY | ||||||
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.19 | General |
| Category: Cardiovascular | ||||||
| 04/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Inflammation | ||||||
| 03/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Cardiology | ||||||
| 03/14/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: ANTI-ANXIETY | ||||||
| 03/13/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Diabetes | ||||||
| 02/15/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: ANTI-ANXIETY | ||||||
| 02/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: ANTI-ANXIETY | ||||||
| 01/17/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: WATCHMAN FLX_IC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 944 | 1,430 | $181,853 | $80,427 |
| 2022 | 28 | 1,853 | 2,392 | $186,224 | $91,791 |
| 2021 | 28 | 2,373 | 3,564 | $210,412 | $107,279 |
| 2020 | 28 | 1,996 | 2,847 | $169,372 | $74,952 |
Total Patients
7,166
Total Services
10,233
Medicare Billing
$354,449
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 3 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 50 | 85 | $13,005 | $6,656 | 51.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 38 | 42 | $12,348 | $6,333 | 51.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 230 | 305 | $7,625 | $4,084 | 53.6% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 58 | 58 | $4,640 | $3,853 | 83.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 265 | 352 | $7,060 | $3,717 | 52.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 65 | $6,890 | $3,486 | 50.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 42 | 51 | $5,406 | $2,700 | 49.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 47 | 49 | $3,054 | $1,832 | 60.0% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 34 | 38 | $2,515 | $1,719 | 68.3% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 106 | 160 | $3,040 | $1,554 | 51.1% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2021 | 152 | 231 | $3,003 | $1,495 | 49.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 267 | 447 | $2,235 | $1,341 | 60.0% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 18 | 29 | $3,103 | $1,029 | 33.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 67 | 67 | $1,876 | $1,023 | 54.5% |
| 17000 | Destruction of skin growth | Office | 2021 | 20 | 22 | $2,420 | $969.80 | 40.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2021 | 66 | 86 | $1,376 | $727.56 | 52.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 17 | 18 | $1,260 | $683.83 | 54.3% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 12 | 12 | $1,255 | $614.82 | 49.0% |
| 71045 | X-ray of chest, 1 view | Office | 2021 | 42 | 54 | $2,138 | $592.33 | 27.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 108 | 173 | $1,066 | $548.41 | 51.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 47 | 57 | $1,269 | $534.48 | 42.1% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 17 | 18 | $1,530 | $389.18 | 25.4% |
| 85610 | Blood test, clotting time | Office | 2021 | 18 | 78 | $624.00 | $334.62 | 53.6% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2021 | 17 | 17 | $765.00 | $244.02 | 31.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 18 | 19 | $494.00 | $184.62 | 37.4% |
About Dr. Mark Bradshaw, M.D
Dr. Mark Bradshaw, M.D is a Family Medicine healthcare provider based in Wynne, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346355518.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Bradshaw, M.D has received a total of $5,627 in payments from pharmaceutical and medical device companies, with $425.06 received in 2024. These payments were reported across 369 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,606).
As a Medicare-enrolled provider, Bradshaw has provided services to 7,166 Medicare beneficiaries, totaling 10,233 services with total Medicare billing of $354,449. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Wynne, AR
- Active Since 08/20/2006
- Last Updated 03/29/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1346355518
Products in Payments
- ELIQUIS (Drug) $519.94
- UBRELVY (Drug) $479.27
- Ozempic (Drug) $459.95
- TRELEGY ELLIPTA (Drug) $327.87
- JARDIANCE (Drug) $287.69
- QULIPTA (Drug) $257.08
- FARXIGA (Drug) $210.70
- XARELTO (Drug) $189.93
- Tresiba (Drug) $169.71
- ENTRESTO (Drug) $161.49
- GEMTESA (Drug) $158.89
- CHANTIX (Drug) $158.48
- Victoza (Drug) $142.01
- INVOKANA (Drug) $138.56
- AREXVY (Drug) $123.74
- LOREEV XR (Drug) $121.83
- Ranexa (Drug) $100.00
- Utibron (Drug) $93.82
- LYRICA (Drug) $88.16
- TOUJEO (Drug) $85.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wynne
Dr. Willard Burks, M.d, M.D
Family Medicine — Payments: $5,354
Family Medicine $5,354
Dr. James Cathey, M.d, M.D
Family Medicine — Payments: $4,594
Family Medicine $4,594
Dr. James Beaton, M.d, M.D
Family Medicine — Payments: $3,374
Family Medicine $3,374
Sean Koch, Md, MD
Family Medicine — Payments: $3,138
Family Medicine $3,138
Jeremiah Nugent, M.d, M.D
Family Medicine — Payments: $2,336
Family Medicine $2,336
Mrs. Lesli Anderson, Aprn, APRN
Family Medicine — Payments: $390.90
Family Medicine $390.90